Showing results (41-50 of 67) with videos related to

Sort By:
Pageof 7
Scientific Reports|February 24, 2018
Hakai overexpression effectively induces tumour progression and metastasis in vivoRaquel Castosa, Olaia Martinez-Iglesias, Daniel Roca-Lema, et al.
Anticancer Research|September 12, 2013
Gemcitabine and capecitabine as third- or later-line therapy for refractory advanced colorectal cancer: a retrospective studyMercedes Salgado, Margarita Reboredo, Juan Carlos Mendez, et al.
Virchows Archiv : an International Journal of Pathology|June 23, 2009
Expression of Wnt gene family and frizzled receptors in head and neck squamous cell carcinomasSilvia Maria Díaz Prado, Vanessa Medina Villaamil, Guadalupe Aparicio Gallego, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 24, 2005
Irinotecan in combination with fluorouracil in a 48-hour continuous infusion as first-line chemotherapy for elderly patients with metastatic colorectal cancer: a Spanish Cooperative Group for the Treatment of Digestive Tumors studyJavier Sastre, Eugenio Marcuello, Bartomeu Masutti, et al.
International Journal of Molecular Sciences|May 19, 2012
Evaluation of the adenocarcinoma-associated gene AGR2 and the intestinal stem cell marker LGR5 as biomarkers in colorectal cancerManuel Valladares-Ayerbes, Moisés Blanco-Calvo, Margarita Reboredo, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 8, 2025
Predictive factors of efficacy for FTD/TPI plus bevacizumab in refractory metastatic colorectal cancer patients: a subanalysis of the Spanish cohort from the SUNLIGHT phase III trialGemma Soler, Cristina Grávalos, Fernando Rivera, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 27, 2010
Evaluation of plakophilin-3 mRNA as a biomarker for detection of circulating tumor cells in gastrointestinal cancer patientsManuel Valladares-Ayerbes, Silvia Díaz-Prado, Margarita Reboredo, et al.
Clinical Colorectal Cancer|March 20, 2018
A Randomized Phase II Study of Axitinib as Maintenance Therapy After First-line Treatment for Metastatic Colorectal CancerCristina Grávalos, Alfredo Carrato, María Tobeña, et al.
Journal of Translational Medicine|September 8, 2012
Circulating miR-200c as a diagnostic and prognostic biomarker for gastric cancerManuel Valladares-Ayerbes, Margarita Reboredo, Vanessa Medina-Villaamil, et al.
The Oncologist|May 31, 2012
Circulating tumor cell count is a prognostic factor in metastatic colorectal cancer patients receiving first-line chemotherapy plus bevacizumab: a Spanish Cooperative Group for the Treatment of Digestive Tumors studyJavier Sastre, M Luisa Maestro, Auxiliadora Gómez-España, et al.
Pageof 7